According to the National Institutes of Health, skin disorders account for 40% of occupational-disease claims nationally. RenovaCare, Inc. is a biotech company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Our initial products under development target the body’s largest organ, the skin. Their flagship technology, the CellMist™ System, uses our patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds. In investigative clinical use in the United States, SkinGun™ treatments have shown the potential to naturally and rapidly heal burns and other serious wounds.